苏尼蒂尼布和结核淋巴腺炎:瘤治疗中的一个意想不到的联系:一个病例报告
Mi-Ran Han1,2, Kyu-Yun Jang1,3, So-Yeon Jeon1,2
1Division of Hematology/Oncology, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
结核性淋巴腺炎是苏尼替尼的罕见副作用,苏尼替尼是一种用于胃肠道 stromal 瘤 (GIST) 的氨酸激酶抑制剂. 这一案例凸显了考虑罕见的副作用的重要性,即使它们不常见.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 胃肠道 stromal 瘤 (GIST) 是胃肠道的罕见间瘤.
- 苏尼蒂尼布是一种多向的氨酸激酶抑制剂,用于作为高级GIST的二线治疗.
- 常见的sunitinib副作用包括高血压,疲劳,中性质衰竭和皮肤反应.
研究的目的:
- 报告一种罕见的结核淋巴腺炎病例,作为苏尼替尼治疗的不良影响,该病例发生在GIST复发的患者身上.
- 讨论sunitinib的抗血管性质与感染性并发症的发展之间的潜在联系.
主要方法:
- 一名患有复发性GIST的患者在伊马替尼布失败后接受了苏尼蒂尼布15个月.
- 患者出现了暗示感染的症状,导致调查.
- 结核性淋巴腺炎的诊断通过淋巴结活检得到证实.
主要成果:
- 在接受sunitinib治疗的患者中诊断出结核淋巴炎GIST.
- 患者接受了抗结核药物治疗,最初的淋巴腺病变有所改善.
- 尽管进行了治疗调整,但GIST进展,患者最终死亡.
结论:
- 结核淋巴腺炎可以作为与sunitinib治疗相关的罕见不良事件发生.
- 虽然sunitinib的抗血管性作用可能很少导致感染,但这种关联非常罕见.
- 这一案例强调了对向癌症治疗的罕见副作用需要保持警.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Targeted Cancer Therapies
There are several types of targeted therapies against...
